Patent 10570380 was granted and assigned to AM-Pharma B.V. on February, 2020 by the United States Patent and Trademark Office.
The invention relates to the field of downstream processing (DSP) of an alkaline phosphatase (AP). More specifically, it relates to a method for reducing host cell protein content in a composition comprising AP. The invention further relates to a composition comprising an AP and a reduced content of a host cell protein.